Combined Results of Two Phase Il Studies of Taxol (Paclitaxel) in Patients with Relapsed or Refractory Lymphomas-Reference-Cited by-同舟云学术

Combined Results of Two Phase Il Studies of Taxol (Paclitaxel) in Patients with Relapsed or Refractory Lymphomas

Published:1999-01 Issue:3-4 Volume:34 Page:295-304
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Goss Paul,Stewart A. Keith,Couture Felix,Klasa Richard,Glück Stefan,Kaizer Leonard,Burkes Ronald,Charpentier Danielle,Palmer Martin,Tye Lesley,Dulude Helene

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428199909050954

Reference29 articles.

1. A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma.

2. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

3. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of paclitaxel and resveratrol on blood characteristics in rabbits;Biotechnic & Histochemistry;2019-10-01

2. Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study;Leukemia & Lymphoma;2017-06-09

3. Complications neurologiques centrales des traitements anticancéreux, ce que le réanimateur doit savoir;Médecine Intensive Réanimation;2017-01-11

4. Resveratrol: A Natural Polyphenol with Multiple Chemopreventive Properties (Review);Current Drug Metabolism;2009-07-01

5. Results of a clinical phase I dose-escalation study of cytarabinein combination with fixed-dose vinorelbine, paclitaxel, etoposideand cisplatin for the treatment of relapsed/refractory lymphoma;Leukemia & Lymphoma;2006-01